Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Current or prospective ownership or investment interest | $38,312 | 5 | 88.9% |
| Food and Beverage | $4,379 | 229 | 10.2% |
| Travel and Lodging | $342.70 | 2 | 0.8% |
| Education | $57.69 | 2 | 0.1% |
| Consulting Fee | $14.90 | 1 | 0.0% |
| Unspecified | $0 | 4 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ozark Cryosurgery, LLC | $38,312 | 9 | $0 (2021) |
| Astellas Pharma US Inc | $975.51 | 65 | $0 (2024) |
| PROCEPT BioRobotics Corporation | $616.23 | 9 | $0 (2024) |
| Boston Scientific Corporation | $320.01 | 9 | $0 (2022) |
| Organogenesis Inc. | $316.52 | 13 | $0 (2024) |
| Axonics, Inc. | $212.35 | 7 | $0 (2023) |
| Sumitomo Pharma America, Inc. | $210.88 | 10 | $0 (2024) |
| Janssen Biotech, Inc. | $201.44 | 13 | $0 (2024) |
| PFIZER INC. | $189.23 | 14 | $0 (2024) |
| COLOPLAST CORP | $185.49 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $953.95 | 39 | Organogenesis Inc. ($235.17) |
| 2023 | $616.98 | 28 | Sumitomo Pharma America, Inc. ($126.11) |
| 2022 | $646.27 | 31 | Myovant Sciences Inc. ($112.05) |
| 2021 | $4,107 | 26 | Ozark Cryosurgery, LLC ($3,312) |
| 2020 | $6,732 | 19 | Ozark Cryosurgery, LLC ($6,500) |
| 2019 | $9,033 | 38 | Ozark Cryosurgery, LLC ($8,500) |
| 2018 | $10,046 | 33 | Ozark Cryosurgery, LLC ($9,500) |
| 2017 | $10,970 | 29 | Ozark Cryosurgery, LLC ($10,500) |
All Payment Transactions
243 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $20.43 | General |
| Category: UROTHELIAL CANCER | ||||||
| 12/05/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $27.68 | General |
| Category: HORMONE THERAPY | ||||||
| 12/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.72 | General |
| Category: NEUROLOGY | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: Oncology | ||||||
| 11/06/2024 | COLOPLAST CORP | Titan (Device) | Food and Beverage | In-kind items and services | $59.42 | General |
| Category: Men's Health | ||||||
| 10/23/2024 | Organogenesis Inc. | PURAPLY AM (Device) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: WOUND CARE | ||||||
| 10/22/2024 | BK Medical Holding Company Inc. | bk3000, bk3500 & bk5000 Ultrasound System (Device) | Food and Beverage | Cash or cash equivalent | $57.62 | General |
| Category: General-purpose ultrasound imaging system | ||||||
| 10/14/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $24.57 | General |
| Category: Oncology | ||||||
| 10/07/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 09/23/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Oncology | ||||||
| 09/20/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $44.35 | General |
| Category: UROLOGY | ||||||
| 09/16/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $18.39 | General |
| 09/11/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $14.93 | General |
| Category: Oncology | ||||||
| 09/04/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $13.61 | General |
| Category: ONCOLOGY | ||||||
| 08/26/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $54.03 | General |
| 08/15/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $19.54 | General |
| Category: HORMONE THERAPY | ||||||
| 08/14/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/01/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $12.83 | General |
| Category: UROLOGY | ||||||
| 07/29/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Oncology | ||||||
| 07/09/2024 | PROCEPT BioRobotics Corporation | AQUABEAM SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $5.77 | General |
| Category: UROLOGY | ||||||
| 06/27/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: HORMONE THERAPY | ||||||
| 06/20/2024 | Organogenesis Inc. | — | Food and Beverage | In-kind items and services | $52.10 | General |
| 06/12/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: ENDOCRINOLOGY | ||||||
| 06/10/2024 | Janssen Biotech, Inc. | ERLEADA (Drug), AKEEGA | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 33 | 2,468 | 6,446 | $688,936 | $190,043 |
| 2022 | 30 | 2,557 | 3,605 | $654,670 | $181,809 |
| 2021 | 32 | 2,859 | 3,979 | $707,983 | $208,832 |
| 2020 | 26 | 2,693 | 3,772 | $707,457 | $197,336 |
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 30 | 312 | $202,800 | $41,897 | 20.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 491 | 586 | $75,588 | $32,561 | 43.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 111 | 141 | $57,270 | $20,866 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 113 | 130 | $24,570 | $11,098 | 45.2% |
| 74178 | Ct scan of abdomen and pelvis before and after contrast | Office | 2023 | 48 | 49 | $43,102 | $8,598 | 19.9% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 19 | 21 | $39,690 | $8,529 | 21.5% |
| J9030 | Bcg live intravesical instillation, 1 mg | Office | 2023 | 11 | 3,000 | $11,280 | $6,684 | 59.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 19 | 20 | $18,000 | $6,139 | 34.1% |
| 52601 | Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope | Facility | 2023 | 11 | 11 | $17,787 | $5,745 | 32.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 39 | 39 | $11,271 | $4,606 | 40.9% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 19 | 20 | $10,604 | $4,538 | 42.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 59 | 59 | $11,151 | $4,080 | 36.6% |
| 51720 | Instillation of anti-cancer drug into bladder | Office | 2023 | 11 | 59 | $14,750 | $3,626 | 24.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 31 | 33 | $8,151 | $3,088 | 37.9% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 513 | 729 | $10,935 | $2,865 | 26.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 71 | 71 | $5,467 | $2,831 | 51.8% |
| 52352 | Removal or manipulation of stone in ureter or kidney using an endoscope | Facility | 2023 | 13 | 13 | $13,572 | $2,235 | 16.5% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 14 | 14 | $5,152 | $2,164 | 42.0% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 38 | 96 | $8,160 | $2,069 | 25.4% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 19 | 19 | $4,275 | $1,834 | 42.9% |
| 74176 | Ct scan of abdomen and pelvis without contrast | Office | 2023 | 24 | 26 | $18,505 | $1,826 | 9.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 204 | 278 | $28,634 | $1,803 | 6.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 229 | 269 | $1,846 | $1,723 | 93.3% |
| 74177 | Ct scan of abdomen and pelvis with contrast | Office | 2023 | 11 | 11 | $10,364 | $1,531 | 14.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 23 | $3,013 | $1,353 | 44.9% |
About Dr. Hunter Brown, MD
Dr. Hunter Brown, MD is a Urology healthcare provider based in Batesville, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1831168913.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hunter Brown, MD has received a total of $43,107 in payments from pharmaceutical and medical device companies, with $953.95 received in 2024. These payments were reported across 243 transactions from 47 companies. The most common payment nature is "Current or prospective ownership or investment interest" ($38,312).
As a Medicare-enrolled provider, Brown has provided services to 10,577 Medicare beneficiaries, totaling 17,802 services with total Medicare billing of $778,021. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Batesville, AR
- Active Since 03/14/2006
- Last Updated 07/28/2010
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1831168913
Products in Payments
- XTANDI (Drug) $598.51
- AQUABEAM ROBOTIC SYSTEM (Device) $485.33
- ORGOVYX (Drug) $345.50
- Myrbetriq (Drug) $216.70
- Axonics (Device) $174.75
- MYRBETRIQ (Drug) $172.71
- ELIGARD (Drug) $167.93
- Xtandi (Drug) $162.55
- LUPRON DEPOT (Drug) $151.78
- GENERAL THERAPIES (Device) $134.38
- AQUABEAM SYSTEM (Device) $130.90
- ERLEADA (Drug) $95.85
- UroLift (Device) $85.08
- Puraply (Medical Supply) $81.35
- Erleada (Drug) $80.64
- PENILE RECONSTRUCTION (Device) $76.76
- Nubeqa (Drug) $67.52
- General - Therapies (Device) $63.67
- Titan (Device) $59.42
- bk3000, bk3500 & bk5000 Ultrasound System (Device) $57.62
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.